Using artificial intelligence to diagnose mycosis fungoides
Part of Cancer, Skin clinical trials.
This study uses artificial intelligence (AI) to look at skin biopsy slides from people with mycosis fungoides, a type of skin lymphoma. The goal is to see if AI can help doctors diagnose this condition more accurately, which could lead to better and earlier treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of mycosis fungoides (a rare type of skin lymphoma).
- Your skin biopsy slides (the tissue samples on glass slides) need to be available for the study.
- The slides must be in good condition—well-stained, not faded, and free from damage or contamination.
- The original diagnosis must be certain, not uncertain or inconclusive.
- The slides must be able to be scanned or digitized without technical problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new artificial intelligence (AI) tool that works with doctors to more accurately diagnose breast cancer that has a large area of early-stage cells (DCIS) mixed with invasive cancer. It may help improve treatment decisions for people with larger, calcified tumors.
This trial uses artificial intelligence to help diagnose seborrheic keratosis, a common harmless skin growth. It aims to see if the AI can accurately identify these growths from skin samples, which could help doctors make faster and more reliable diagnoses.
This study is testing whether an artificial intelligence (AI) system can accurately diagnose basal cell carcinoma, a common type of skin cancer, from microscope slide images. If you have had a biopsy slide of a skin lesion that was already diagnosed as basal cell carcinoma, your sample might be used to help train or test the AI.
This study uses artificial intelligence to help diagnose pattern hair loss (also called androgenetic alopecia) from scalp images. It may help doctors identify the condition more accurately and is testing the AI tool on different types of patients.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
Hear when a new Artificial Intelligence (AI) in Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.